TEM micrographs show a transition from nanosized particles to cluster formation with increase in phosphor concentration. The green long-lasting phosphorescence of the composites was observed in the dark after removal of the excitation light. Photoluminescence (PL) was observed in the composites

of both polymers for phosphor volume concentrations above 1.0% for PMMA JNJ-26481585 and above 0.5% for LDPE. For each of these samples, a broad PL peak at about 505 nm wavelength was observed after excitation at 350 nm with a xenon lamp. For the LDPE composites, the DSC results show that the presence of the phosphor in the polymer has no major influence on either the melting temperature or enthalpy values of the polymer. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 117: 2635-2640, 2010″
“This study examined two issues. One, whether individuals with possible substance use disorders were more likely to be admitted to specialized chemical dependency

(CD) treatment after receiving a brief intervention (BI) – either alone or in combination with other services – than similar individuals who did not receive a BI. Two, whether participation in brief treatment (BT) following a BI was helpful in facilitating admission to CD treatment. The study took place in the emergency ISRIB research buy department (ED) of a large urban safety-net hospital where CD professionals screened patients for alcohol/drug problems and provided BI, BT, and referral to specialized CD treatment when appropriate (SBIRT). Substance use disorders were indicated by alcohol/drug problems noted in administrative records. Hospital records were used to match patients with likely substance use disorders who received BI with similar ED patients who had not been screened. Admission to publicly GSK2245840 supplier funded CD treatment was determined by matching

patient identifiers to state administrative records of CD treatment. Results indicated that individuals with a likely substance use disorder who received a BI (regardless of subsequent participation in BT) were significantly more likely to enter specialized CD treatment in the subsequent year than similar individuals who did not receive a BI. This result was particularly pronounced for patients with no CD treatment in the past two years. Results also indicated that participation in BT facilitated admission into CD treatment. The results suggest that SBIRT programs could serve an important role in increasing entry to specialized treatment for individuals with substance use disorders. (c) 2010 Elsevier Ireland Ltd. All rights reserved.”
“Background: Widespread use of recombinant human bone morphogenetic protein (rhBMP) in cervical spine surgery has continued despite the U.S. Food and Drug Administration’s 2008 notification regarding its adverse effects.